284 related articles for article (PubMed ID: 30626647)
1. Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency.
Veiga-da-Cunha M; Chevalier N; Stephenne X; Defour JP; Paczia N; Ferster A; Achouri Y; Dewulf JP; Linster CL; Bommer GT; Van Schaftingen E
Proc Natl Acad Sci U S A; 2019 Jan; 116(4):1241-1250. PubMed ID: 30626647
[TBL] [Abstract][Full Text] [Related]
2. SLGT2 Inhibitor Rescues Myelopoiesis in G6PC3 Deficiency.
Hiwarkar P; Bargir U; Pandrowala A; Bodhanwala M; Thakker N; Taur P; Madkaikar M; Desai M
J Clin Immunol; 2022 Nov; 42(8):1653-1659. PubMed ID: 35838821
[TBL] [Abstract][Full Text] [Related]
3. DBS are suitable for 1,5-anhydroglucitol monitoring in GSD1b and G6PC3-deficient patients taking SGLT2 inhibitors to treat neutropenia.
Dewulf JP; Chevalier N; Marie S; Veiga-da-Cunha M
Mol Genet Metab; 2023 Nov; 140(3):107712. PubMed ID: 38353183
[TBL] [Abstract][Full Text] [Related]
4. SGLT5 is the renal transporter for 1,5-anhydroglucitol, a major player in two rare forms of neutropenia.
Diederich J; Mounkoro P; Tirado HA; Chevalier N; Van Schaftingen E; Veiga-da-Cunha M
Cell Mol Life Sci; 2023 Aug; 80(9):259. PubMed ID: 37594549
[TBL] [Abstract][Full Text] [Related]
5. Successful use of empagliflozin to treat neutropenia in two G6PC3-deficient children: Impact of a mutation in SGLT5.
Boulanger C; Stephenne X; Diederich J; Mounkoro P; Chevalier N; Ferster A; Van Schaftingen E; Veiga-da-Cunha M
J Inherit Metab Dis; 2022 Jul; 45(4):759-768. PubMed ID: 35506446
[TBL] [Abstract][Full Text] [Related]
6. Lack of glucose recycling between endoplasmic reticulum and cytoplasm underlies cellular dysfunction in glucose-6-phosphatase-beta-deficient neutrophils in a congenital neutropenia syndrome.
Jun HS; Lee YM; Cheung YY; McDermott DH; Murphy PM; De Ravin SS; Mansfield BC; Chou JY
Blood; 2010 Oct; 116(15):2783-92. PubMed ID: 20498302
[TBL] [Abstract][Full Text] [Related]
7. Treatment of the Neutropenia Associated with GSD1b and G6PC3 Deficiency with SGLT2 Inhibitors.
Veiga-da-Cunha M; Wortmann SB; Grünert SC; Van Schaftingen E
Diagnostics (Basel); 2023 May; 13(10):. PubMed ID: 37238286
[TBL] [Abstract][Full Text] [Related]
8. Survival and differentiation defects contribute to neutropenia in glucose-6-phosphatase-β (G6PC3) deficiency in a model of mouse neutrophil granulocyte differentiation.
Gautam S; Kirschnek S; Gentle IE; Kopiniok C; Henneke P; Häcker H; Malleret L; Belaaouaj A; Häcker G
Cell Death Differ; 2013 Aug; 20(8):1068-79. PubMed ID: 23686134
[TBL] [Abstract][Full Text] [Related]
9. The SGLT2-inhibitor dapagliflozin improves neutropenia and neutrophil dysfunction in a mouse model of the inherited metabolic disorder GSDIb.
Resaz R; Raggi F; Segalerba D; Lavarello C; Gamberucci A; Bosco MC; Astigiano S; Assunto A; Melis D; D'Acierno M; Veiga-da-Cunha M; Petretto A; Marcolongo P; Trepiccione F; Eva A
Mol Genet Metab Rep; 2021 Dec; 29():100813. PubMed ID: 34712576
[TBL] [Abstract][Full Text] [Related]
10. Hypothesis: A Novel Neuroprotective Role for Glucose-6-phosphatase (G6PC3) in Brain-To Maintain Energy-Dependent Functions Including Cognitive Processes.
Dienel GA
Neurochem Res; 2020 Nov; 45(11):2529-2552. PubMed ID: 32815045
[TBL] [Abstract][Full Text] [Related]
11. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes.
Chou JY; Jun HS; Mansfield BC
J Inherit Metab Dis; 2015 May; 38(3):511-9. PubMed ID: 25288127
[TBL] [Abstract][Full Text] [Related]
12. Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter.
Chen LY; Shieh JJ; Lin B; Pan CJ; Gao JL; Murphy PM; Roe TF; Moses S; Ward JM; Lee EJ; Westphal H; Mansfield BC; Chou JY
Hum Mol Genet; 2003 Oct; 12(19):2547-58. PubMed ID: 12925567
[TBL] [Abstract][Full Text] [Related]
13. Glucose-6-phosphate transporter mediates macrophage proliferation and functions by regulating glycolysis and mitochondrial respiration.
Jeon EH; Park TS; Jang Y; Hwang E; Kim SJ; Song KD; Weinstein DA; Lee YM; Park BC; Jun HS
Biochem Biophys Res Commun; 2020 Mar; 524(1):89-95. PubMed ID: 31980167
[TBL] [Abstract][Full Text] [Related]
14. The SLC37 family of phosphate-linked sugar phosphate antiporters.
Chou JY; Sik Jun H; Mansfield BC
Mol Aspects Med; 2013; 34(2-3):601-11. PubMed ID: 23506893
[TBL] [Abstract][Full Text] [Related]
15. Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor.
Wortmann SB; Van Hove JLK; Derks TGJ; Chevalier N; Knight V; Koller A; Oussoren E; Mayr JA; van Spronsen FJ; Lagler FB; Gaughan S; Van Schaftingen E; Veiga-da-Cunha M
Blood; 2020 Aug; 136(9):1033-1043. PubMed ID: 32294159
[TBL] [Abstract][Full Text] [Related]
16. SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphate antiporters.
Pan CJ; Chen SY; Jun HS; Lin SR; Mansfield BC; Chou JY
PLoS One; 2011; 6(9):e23157. PubMed ID: 21949678
[TBL] [Abstract][Full Text] [Related]
17. A molecular signature for the G6PC3/SLC37A2/SLC37A4 interactors in glioblastoma disease progression and in the acquisition of a brain cancer stem cell phenotype.
Torabidastgerdooei S; Roy ME; Annabi B
Front Endocrinol (Lausanne); 2023; 14():1265698. PubMed ID: 38034009
[TBL] [Abstract][Full Text] [Related]
18. Structure-function analysis of the glucose-6-phosphate transporter deficient in glycogen storage disease type Ib.
Chen LY; Pan CJ; Shieh JJ; Chou JY
Hum Mol Genet; 2002 Dec; 11(25):3199-207. PubMed ID: 12444104
[TBL] [Abstract][Full Text] [Related]
19. Neutropenia in type Ib glycogen storage disease.
Chou JY; Jun HS; Mansfield BC
Curr Opin Hematol; 2010 Jan; 17(1):36-42. PubMed ID: 19741523
[TBL] [Abstract][Full Text] [Related]
20. Inborn errors of metabolite repair.
Veiga-da-Cunha M; Van Schaftingen E; Bommer GT
J Inherit Metab Dis; 2020 Jan; 43(1):14-24. PubMed ID: 31691304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
